Literature DB >> 12462194

Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration.

L Davel1, A D'Agostino, A Español, M A Jasnis, L Lauría de Cidre, E S de Lustig, M E Sales.   

Abstract

Nitric oxide (NO), produced by distinct nitric oxide synthase (NOS) isoforms, and prostaglandins generated by expression of cyclooxygenases are important mediators in tumor progression. Previous studies have shown that NO can influence the formation of prostaglandin E2 (PGE2). We provide evidence that NO, derived from iNOS and eNOS activity in LMM3 murine mammary adenocarcinoma cell line, is involved in tumor angiogenesis and in tumor cell migration. LMM3 cells that also stimulate their neovascularization activity and migration liberate high basal amounts of PGE2. There is large amount of evidence that postulates positive regulatory interactions between NOS and cyclooxygenase (COX) isoforms. We here show that, in the LMM3 cell line, while PGE2 exerts a positive modulation on NOS activity, NO closes the loop with a negative feed back on COX activity. We also provide evidence of a positive regulatory effect of protein tyrosine kinases on NOS as well as on COX enzymatic functions affecting tumor induced angiogenesis and cell migration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462194

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  6 in total

1.  Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ling Li; Bing-Zhong Sun; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Nitric oxide synthase 1 and cyclooxygenase-2 enzymes are targets of muscarinic activation in normal and inflamed NIH3T3 cells.

Authors:  A J Español; N Goren; M L Ribeiro; María Elena Sales
Journal:  Inflamm Res       Date:  2009-10-13       Impact factor: 4.575

3.  Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.

Authors:  Eulalia de la Torre; Lilia Davel; María A Jasnis; Tomomi Gotoh; Eugenia Sacerdote de Lustig; María E Sales
Journal:  Breast Cancer Res       Date:  2005-03-04       Impact factor: 6.466

4.  Edaravone acts as a potential therapeutic drug against pentylenetetrazole-induced epilepsy in male albino rats by downregulating cyclooxygenase-II.

Authors:  Liang-Min Liu; Ning Wang; Yan Lu; Wei-Ping Wang
Journal:  Brain Behav       Date:  2018-12-01       Impact factor: 2.708

5.  Rosiglitazone inhibits metastasis development of a murine mammary tumor cell line LMM3.

Authors:  Gabriela Magenta; Ximena Borenstein; Romina Rolando; María Adela Jasnis
Journal:  BMC Cancer       Date:  2008-02-08       Impact factor: 4.430

6.  KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.

Authors:  María Victoria Medina; Agata D Agostino; Qi Ma; Pilar Eroles; Lucas Cavallin; Chiara Chiozzini; Daiana Sapochnik; Cora Cymeryng; Elizabeth Hyjek; Ethel Cesarman; Julian Naipauer; Enrique A Mesri; Omar A Coso
Journal:  PLoS Pathog       Date:  2020-10-15       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.